Clinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington’s disease

被引:0
|
作者
Federica Agosta
Daniele Altomare
Cristina Festari
Stefania Orini
Federica Gandolfo
Marina Boccardi
Javier Arbizu
Femke Bouwman
Alexander Drzezga
Peter Nestor
Flavio Nobili
Zuzana Walker
Marco Pagani
机构
[1] Vita-Salute San Raffaele University,Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute
[2] IRCCS S. Giovanni di Dio,LANE – Laboratory of Alzheimer’s Neuroimaging & Epidemiology
[3] Fatebenefratelli,Department of Molecular and Translational Medicine
[4] University of Brescia,Alzheimer Operative Unit
[5] IRCCS S. Giovanni di Dio,LANVIE (Laboratoire de Neuroimagerie du Vieillissement), Department of Psychiatry
[6] Fatebenefratelli,Department of Nuclear Medicine, Clinica Universidad de Navarra
[7] University of Geneva,Department of Neurology & Alzheimer Center, Amsterdam Neuroscience
[8] University of Navarra,Department of Nuclear Medicine
[9] VU University Medical Center,Queensland Brain Institute
[10] University Hospital of Cologne,Department of Neuroscience (DINOGMI)
[11] University of Cologne and German Center for Neurodegenerative Diseases (DZNE),Division of Psychiatry & Essex Partnership University NHS Foundation Trust
[12] German Center for Neurodegenerative Diseases (DZNE),Department of Nuclear Medicine
[13] University of Queensland and at the Mater Hospital Brisbane,undefined
[14] University of Genoa and Polyclinic San Martino Hospital,undefined
[15] University College London,undefined
[16] Institute of Cognitive Sciences and Technologies,undefined
[17] CNR,undefined
[18] Karolinska Hospital Stockholm,undefined
关键词
FDG-PET; Amyotrophic lateral sclerosis; Huntington’s disease; Cognitive impairment; Behavioral abnormalities; Mutation gene carrier;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1546 / 1556
页数:10
相关论文
共 50 条
  • [31] Utility of FDG-PET in clinical neuroendocrine prostate cancer
    Spratt, Daniel E.
    Gavane, Somali
    Tarlinton, Lisa
    Fareedy, Shoaib B.
    Doran, Michael G.
    Zelefsky, Michael J.
    Osborne, Joseph R.
    PROSTATE, 2014, 74 (11): : 1153 - 1159
  • [32] Clinical Utility of [18F]FDG-PET /CT in Pericardial Disease
    Kim, Min-Sun
    Kim, Eun-Kyung
    Choi, Joon Young
    Oh, Jae K.
    Chang, Sung-A
    CURRENT CARDIOLOGY REPORTS, 2019, 21 (09)
  • [33] Coupling motor evoked potentials and brain [18F]FDG-PET in Amyotrophic Lateral Sclerosis: preliminary findings on disease severity
    Tondo, Giacomo
    Mazzini, Letizia
    Caminiti, Silvia Paola
    Gallo, Chiara
    Matheoud, Roberta
    Comi, Cristoforo
    Sacchetti, Gian Mauro
    Perani, Daniela
    De Marchi, Fabiola
    NEUROBIOLOGY OF DISEASE, 2024, 199
  • [34] FDG-PET/CT in presymptomatic and symptomatic Huntington's disease: Possible predictor of disease progression?
    Lopez, D.
    Camacho, V.
    Fernandez, A.
    Perez Perez, J.
    Martinez-Horta, S.
    Sampedro, F.
    Achury, C.
    Jaller, R.
    Montes, A.
    Carrio, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S273 - S274
  • [36] Oxytocin in Huntington's disease and the spectrum of amyotrophic lateral sclerosis-frontotemporal dementia
    Bergh, Sofia
    Cheong, Rachel Y.
    Petersen, Asa
    Gabery, Sanaz
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2022, 15
  • [37] On the hunt for a link between genetically confirmed Huntington's disease and Amyotrophic Lateral Sclerosis
    Williams, L.
    O'Connell, K.
    Burke, D.
    Cryan, J.
    McCabe, D.
    MOVEMENT DISORDERS, 2018, 33 : S381 - S381
  • [38] CO-OCCURRENCE OF AMYOTROPHIC LATERAL SCLEROSIS AND HUNTINGTON'S DISEASE - A SYSTEMATIC REVIEW
    Fung, Wai Lun Alan
    Mah, Harrison
    Gibbons, Clare
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 : A43 - A43
  • [39] Sex-related differences in amyotrophic lateral sclerosis: A 2-[18F]FDG-PET study
    Canosa, Antonio
    Martino, Alessio
    Manera, Umberto
    Giuliani, Alessandro
    Vasta, Rosario
    Palumbo, Francesca
    Grassano, Maurizio
    Morbelli, Silvia Daniela
    Pardini, Matteo
    Chiaravalloti, Agostino
    Schillaci, Orazio
    Leenders, Klaus Leonard
    Kogan, Rosalie Vered
    Polverari, Giulia
    Zocco, Grazia
    Di Pede, Francesca
    Mattei, Filippo De
    Cabras, Sara
    Matteoni, Enrico
    Moglia, Cristina
    Calvo, Andrea
    Chio, Adriano
    Pagani, Marco
    EUROPEAN JOURNAL OF NEUROLOGY, 2025, 32 (01)
  • [40] Clinical utility of FDG-PET in staging and assessment of therapy in melanoma
    McNamara, D.
    Chevreau, C.
    Zerdoud, S.
    Caselles, O.
    Girault, S.
    Gancel, M.
    Courbon, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S151 - S151